|
Schwartz, J B (1996) Calcium antagonists in the elderly. A risk-benefit analysis. Drugs Aging 9:24-36
|
|
Craft, N; Schwartz, J B (1995) Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans. Am J Physiol 268:H1441-52
|
|
Harris, R Z; Benet, L Z; Schwartz, J B (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs 50:222-39
|
|
Schwartz, J B; Shen, C; Garcia, J et al. (1995) Influence of autonomic blockade and aging on AV conduction and responses to verapamil in the beagle. J Gerontol A Biol Sci Med Sci 50:M83-90
|
|
Schwartz, J B; Capili, H; Daugherty, J (1994) Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 55:509-17
|
|
Kusumoto, F M; Lurie, K G; Dutton, J et al. (1994) Effects of aging on AV nodal and ventricular beta-adrenergic receptors in the Fischer 344 rat. Am J Physiol 266:H1408-15
|
|
Schwartz, J B; Capili, H; Wainer, I W (1994) Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers. Clin Pharmacol Ther 56:368-76
|
|
Schwartz, J B; Caputo, G; Abbott, J (1993) Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS. J Am Geriatr Soc 41:967-74
|
|
Schwartz, J B; Troconiz, I F; Verotta, D et al. (1993) Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil. J Pharmacol Exp Ther 265:690-8
|
|
Schrader, R; Brooks, M; Echt, D S (1992) Effects of verapamil and Bay K 8644 on defibrillation energy requirements in dogs. J Cardiovasc Pharmacol 19:839-50
|
Showing the most recent 10 out of 16 publications
